Nikki Hafezi

Nikki Hafezi Challenges the Rare Disease Status of Keratoconus

Hafezi addressed the widespread reliance on a 1986 prevalence estimate that places keratoconus at 1 in 2,000—formally classifying it as rare. Yet as she highlighted, emerging epidemiological data tell a starkly different story. Keratoconus is an orphan disease, not a rare one.

Read More

TOS 2025: Advanced CXL and DS advocacy

During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.

Read More

Collaboration: ELZA, MESCA, and BSMI

Nikki Hafezi-Kristoffersen, MAS IP ETHZ, CEO of the ELZA Institute and executive at the MESCA Foundation, recently visited the Bukhara State Medical Institute (BSMI).

Read More

Swiss Days 2024: ELZA’s Impact in Uzbekistan

During Swiss Days 2024 in Tashkent, the ELZA Institute’s CEO, Nikki L. Hafezi, led a keratoconus screening initiative that identified critical cases and strengthened Swiss-Uzbek collaborations. The event, featured on Zo’r TV, highlights ELZA’s global healthcare impact.

Read More
.
.